Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
5
71%

Phase Distribution

0

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
5(71.4%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 25 (71.4%)
N/A2 (28.6%)

Trials by Status

completed457%
withdrawn114%
terminated229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7